Radiopharm Theranostics Limited RADX
Set alert
0.86 USD -0.13 -13.38%
As of Nov 3, 10:03 AM ET
0.8602 Day range 0.945
0.8602 52-week range 16.25
- YTD
- -83.52%
- 1 year
- -83.65%
- Open
- 0.945
- Prev close
- 0.9931
- Mkt cap
- 13.51M
- Vol
- 50.42K
- Avg vol
- 54.62K
- EPS
- -3.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8602
- High
- 0.945
- Forward P/E
- 0.00
- Beta
- 0.85
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.67
- 200-d avg
- 7.67
- 1y target
- 0.00
5D chart
Signals (50)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:45 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 3:45 PM | 18 hours ago |
| RSI: Oversold | Nov 2, 3:45 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 2:35 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 1:45 PM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 1:45 PM | 20 hours ago |
| RSI: Oversold | Nov 2, 1:45 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 1:20 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 1:10 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:10 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 12:45 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 12:40 PM | 21 hours ago |
| RSI: Oversold | Nov 2, 12:40 PM | 21 hours ago |
| RSI: Overbought | Nov 2, 12:15 PM | 22 hours ago |
| MACD: Buy Signal | Nov 2, 10:40 AM | 23 hours ago |
| RSI: Oversold | Nov 2, 9:30 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 11:55 AM | 3 days ago |
Newest 20 of 50.
Financial health
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -1.3×
FY 2021 5y median -0.9× FY 2025
P/S 26.4×
FY 2021 5y median 92.5× FY 2025
P/B 2.9×
FY 2021 5y median 1.1× FY 2025
P/FCF 0.0×
FY 2021 5y median -1.1× FY 2025
EV/EBITDA -1.1×
FY 2021 5y median -0.5× FY 2025
EV/Sales 24.9×
FY 2021 5y median 24.9× FY 2025
FCF Yield 0.0%
FY 2021 5y median -74.9% FY 2025
Profitability
Gross Margin -77.7%
FY 2021 5y median 100.0% FY 2025
Operating Margin -2468.6%
FY 2021 5y median -11803.3% FY 2025
Net Margin -1992.5%
FY 2021 5y median -11838.6% FY 2025
ROE -218.5%
FY 2021 5y median -85.6% FY 2025
ROIC -161.9%
FY 2021 5y median -55.9% FY 2025
ROA -89.7%
FY 2021 5y median -46.2% FY 2025
Growth (YoY)
Revenue -25.5%
FY 2021 FY 2025
Operating Income -75.1%
FY 2021 FY 2025
EPS (diluted) 13.6%
FY 2021 FY 2025
Free Cash Flow 100.0%
FY 2021 FY 2025
Financial Health
Current Ratio 1.2×
FY 2021 5y median 1.3× FY 2025
Quick Ratio 1.2×
FY 2021 5y median 1.3× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2021 5y median 0.4× FY 2025
Interest Coverage -608×
FY 2021 5y median -401× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2026-06-30
